CA2710764A1 - Methods for enhancing muscle performance and tone - Google Patents

Info

Publication number

CA2710764A1

CA2710764A1 CA2710764A CA2710764A CA2710764A1 CA 2710764 A1 CA2710764 A1 CA 2710764A1 CA 2710764 A CA2710764 A CA 2710764A CA 2710764 A CA2710764 A CA 2710764A CA 2710764 A1 CA2710764 A1 CA 2710764A1

Authority

CA

Canada

Prior art keywords

subject

agonist

ampk

exercise

muscle

Prior art date

2007-12-28

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 172
• 210000003205 muscle Anatomy 0.000 title claims description 100
• 230000002708 enhancing effect Effects 0.000 title claims description 18
• 239000000556 agonist Substances 0.000 claims abstract description 187
• 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 claims abstract description 24
• 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 claims abstract description 24
• 150000001875 compounds Chemical class 0.000 claims abstract description 23
• 108090000623 proteins and genes Proteins 0.000 claims description 229
• 230000014509 gene expression Effects 0.000 claims description 104
• 102000004169 proteins and genes Human genes 0.000 claims description 96
• 235000018102 proteins Nutrition 0.000 claims description 88
• 230000000694 effects Effects 0.000 claims description 84
• YDBLKRPLXZNVNB-UHFFFAOYSA-N GW 501516 Chemical group CC=1N=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 YDBLKRPLXZNVNB-UHFFFAOYSA-N 0.000 claims description 81
• 239000000203 mixture Substances 0.000 claims description 76
• 230000009183 running Effects 0.000 claims description 63
• 210000002027 skeletal muscle Anatomy 0.000 claims description 63
• 239000003795 chemical substances by application Substances 0.000 claims description 60
• RTRQQBHATOEIAF-UUOKFMHZSA-N acadesine Chemical group NC1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 RTRQQBHATOEIAF-UUOKFMHZSA-N 0.000 claims description 57
• 230000001965 increasing effect Effects 0.000 claims description 54
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 43
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 42
• 230000001105 regulatory effect Effects 0.000 claims description 40
• 229920001184 polypeptide Polymers 0.000 claims description 39
• 230000000276 sedentary effect Effects 0.000 claims description 38
• 239000003814 drug Substances 0.000 claims description 36
• 241000282414 Homo sapiens Species 0.000 claims description 33
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 28
• 239000002572 performance enhancing substance Substances 0.000 claims description 25
• 206010028289 Muscle atrophy Diseases 0.000 claims description 24
• 201000000585 muscular atrophy Diseases 0.000 claims description 24
• 235000014113 dietary fatty acids Nutrition 0.000 claims description 23
• 229930195729 fatty acid Natural products 0.000 claims description 23
• 239000000194 fatty acid Substances 0.000 claims description 23
• 150000004665 fatty acids Chemical class 0.000 claims description 23
• 102000002281 Adenylate kinase Human genes 0.000 claims description 20
• 108020000543 Adenylate kinase Proteins 0.000 claims description 20
• 241000124008 Mammalia Species 0.000 claims description 18
• 230000004547 gene signature Effects 0.000 claims description 17
• 230000001976 improved effect Effects 0.000 claims description 17
• 239000002299 complementary DNA Substances 0.000 claims description 15
• 108010013563 Lipoprotein Lipase Proteins 0.000 claims description 13
• 230000001086 cytosolic effect Effects 0.000 claims description 13
• 238000007254 oxidation reaction Methods 0.000 claims description 13
• 102000000019 Sterol Esterase Human genes 0.000 claims description 12
• 108010055297 Sterol Esterase Proteins 0.000 claims description 12
• 239000012472 biological sample Substances 0.000 claims description 12
• 230000003647 oxidation Effects 0.000 claims description 12
• 208000035475 disorder Diseases 0.000 claims description 11
• 108020004414 DNA Proteins 0.000 claims description 10
• 210000000577 adipose tissue Anatomy 0.000 claims description 10
• 230000003197 catalytic effect Effects 0.000 claims description 10
• 102000004146 ATP citrate synthases Human genes 0.000 claims description 9
• 108090000662 ATP citrate synthases Proteins 0.000 claims description 9
• 108010045374 CD36 Antigens Proteins 0.000 claims description 9
• 102000053028 CD36 Antigens Human genes 0.000 claims description 9
• 108010029485 Protein Isoforms Proteins 0.000 claims description 9
• 102000001708 Protein Isoforms Human genes 0.000 claims description 9
• 241000283073 Equus caballus Species 0.000 claims description 8
• 101000734572 Homo sapiens Phosphoenolpyruvate carboxykinase, cytosolic [GTP] Proteins 0.000 claims description 8
• 102100034796 Phosphoenolpyruvate carboxykinase, cytosolic [GTP] Human genes 0.000 claims description 8
• 210000001789 adipocyte Anatomy 0.000 claims description 8
• 230000020763 muscle atrophy Effects 0.000 claims description 8
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 7
• 241000700159 Rattus Species 0.000 claims description 7
• 230000001737 promoting effect Effects 0.000 claims description 7
• 102100028704 Acetyl-CoA acetyltransferase, cytosolic Human genes 0.000 claims description 6
• 239000004475 Arginine Substances 0.000 claims description 6
• 102100032137 Cell death activator CIDE-3 Human genes 0.000 claims description 6
• 102100035436 Complement factor D Human genes 0.000 claims description 6
• 101710173162 Cysteine dioxygenase 1 Proteins 0.000 claims description 6
• 102100027275 Dual specificity protein phosphatase 7 Human genes 0.000 claims description 6
• 102000013948 Fatty acid-binding protein 4 Human genes 0.000 claims description 6
• 108050003772 Fatty acid-binding protein 4 Proteins 0.000 claims description 6
• 101000837584 Homo sapiens Acetyl-CoA acetyltransferase, cytosolic Proteins 0.000 claims description 6
• 101000775558 Homo sapiens Cell death activator CIDE-3 Proteins 0.000 claims description 6
• 101000737554 Homo sapiens Complement factor D Proteins 0.000 claims description 6
• 101001057603 Homo sapiens Dual specificity protein phosphatase 7 Proteins 0.000 claims description 6
• 101000802091 Homo sapiens Thyroid hormone-inducible hepatic protein Proteins 0.000 claims description 6
• 102000004371 Insulin-like growth factor binding protein 5 Human genes 0.000 claims description 6
• 102000014150 Interferons Human genes 0.000 claims description 6
• 108010050904 Interferons Proteins 0.000 claims description 6
• 108020002334 Monoacylglycerol lipase Proteins 0.000 claims description 6
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 6
• 102000007156 Resistin Human genes 0.000 claims description 6
• 108010047909 Resistin Proteins 0.000 claims description 6
• 102100034700 Thyroid hormone-inducible hepatic protein Human genes 0.000 claims description 6
• 102000014701 Transketolase Human genes 0.000 claims description 6
• 108010043652 Transketolase Proteins 0.000 claims description 6
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 6
• 230000009467 reduction Effects 0.000 claims description 6
• SIARJEKBADXQJG-LFZQUHGESA-N stearoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCCCCCCCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 SIARJEKBADXQJG-LFZQUHGESA-N 0.000 claims description 6
• 238000010254 subcutaneous injection Methods 0.000 claims description 6
• 239000007929 subcutaneous injection Substances 0.000 claims description 6
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 6
• 102100031786 Adiponectin Human genes 0.000 claims description 5
• 102100029949 Caprin-1 Human genes 0.000 claims description 5
• 101710072528 Caprin-1 Proteins 0.000 claims description 5
• 102100024650 Carbonic anhydrase 3 Human genes 0.000 claims description 5
• 101710167915 Carbonic anhydrase 3 Proteins 0.000 claims description 5
• 102100028289 Coatomer subunit delta Human genes 0.000 claims description 5
• 102100028523 Cytoplasmic dynein 1 intermediate chain 2 Human genes 0.000 claims description 5
• 102100032826 Homeodomain-interacting protein kinase 3 Human genes 0.000 claims description 5
• 101710110791 Homeodomain-interacting protein kinase 3 Proteins 0.000 claims description 5
• 101000775469 Homo sapiens Adiponectin Proteins 0.000 claims description 5
• 101000860881 Homo sapiens Coatomer subunit delta Proteins 0.000 claims description 5
• 101000915292 Homo sapiens Cytoplasmic dynein 1 intermediate chain 2 Proteins 0.000 claims description 5
• 101001139136 Homo sapiens Krueppel-like factor 3 Proteins 0.000 claims description 5
• 101000665882 Homo sapiens Retinol-binding protein 4 Proteins 0.000 claims description 5
• 108090000961 Insulin-like growth factor binding protein 5 Proteins 0.000 claims description 5
• 102100020678 Krueppel-like factor 3 Human genes 0.000 claims description 5
• 102000014944 Lysosome-Associated Membrane Glycoproteins Human genes 0.000 claims description 5
• 108010064171 Lysosome-Associated Membrane Glycoproteins Proteins 0.000 claims description 5
• 102100026741 Microsomal glutathione S-transferase 1 Human genes 0.000 claims description 5
• 102000017794 Perilipin-2 Human genes 0.000 claims description 5
• 108010067163 Perilipin-2 Proteins 0.000 claims description 5
• 102100038246 Retinol-binding protein 4 Human genes 0.000 claims description 5
• 210000000593 adipose tissue white Anatomy 0.000 claims description 5
• 238000010255 intramuscular injection Methods 0.000 claims description 5
• 239000007927 intramuscular injection Substances 0.000 claims description 5
• 238000010253 intravenous injection Methods 0.000 claims description 5
• 108010074917 microsomal glutathione S-transferase-I Proteins 0.000 claims description 5
• 150000003839 salts Chemical class 0.000 claims description 5
• 108010009575 CD55 Antigens Proteins 0.000 claims description 4
• 102100035762 Diacylglycerol O-acyltransferase 2 Human genes 0.000 claims description 4
• 101710167503 Diacylglycerol O-acyltransferase 2 Proteins 0.000 claims description 4
• 102000014702 Haptoglobin Human genes 0.000 claims description 4
• 108050005077 Haptoglobin Proteins 0.000 claims description 4
• 101000724418 Homo sapiens Neutral amino acid transporter B(0) Proteins 0.000 claims description 4
• 101000640836 Homo sapiens Sodium-coupled neutral amino acid transporter 4 Proteins 0.000 claims description 4
• 102100028267 Neutral amino acid transporter B(0) Human genes 0.000 claims description 4
• 102100033869 Sodium-coupled neutral amino acid transporter 4 Human genes 0.000 claims description 4
• 150000002148 esters Chemical class 0.000 claims description 4
• 229940079322 interferon Drugs 0.000 claims description 4
• 238000001964 muscle biopsy Methods 0.000 claims description 4
• 239000002243 precursor Substances 0.000 claims description 4
• 239000000651 prodrug Substances 0.000 claims description 4
• 229940002612 prodrug Drugs 0.000 claims description 4
• 102100034273 Annexin A7 Human genes 0.000 claims description 3
• 108010039940 Annexin A7 Proteins 0.000 claims description 3
• 102100034808 CCAAT/enhancer-binding protein alpha Human genes 0.000 claims description 3
• 101000945515 Homo sapiens CCAAT/enhancer-binding protein alpha Proteins 0.000 claims description 3
• 101001061518 Homo sapiens RNA-binding protein FUS Proteins 0.000 claims description 3
• 101100340610 Mus musculus Igdcc3 gene Proteins 0.000 claims description 3
• 108010058956 Protein Phosphatase 2 Proteins 0.000 claims description 3
• 102000006478 Protein Phosphatase 2 Human genes 0.000 claims description 3
• 102100028469 RNA-binding protein FUS Human genes 0.000 claims description 3
• 102100020868 Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial Human genes 0.000 claims description 3
• 101710145888 Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial Proteins 0.000 claims description 3
• 102100038182 Vitamin K-dependent gamma-carboxylase Human genes 0.000 claims description 3
• 230000032683 aging Effects 0.000 claims description 3
• 239000003937 drug carrier Substances 0.000 claims description 3
• 108010013113 glutamyl carboxylase Proteins 0.000 claims description 3
• 238000004519 manufacturing process Methods 0.000 claims description 3
• RTRQQBHATOEIAF-UHFFFAOYSA-N AICA riboside Natural products NC1=C(C(=O)N)N=CN1C1C(O)C(O)C(CO)O1 RTRQQBHATOEIAF-UHFFFAOYSA-N 0.000 claims 8
• 102100022119 Lipoprotein lipase Human genes 0.000 claims 1
• 102100029814 Monoglyceride lipase Human genes 0.000 claims 1
• 102000034570 NR1 subfamily Human genes 0.000 claims 1
• 108020001305 NR1 subfamily Proteins 0.000 claims 1
• 108010011376 AMP-Activated Protein Kinases Proteins 0.000 abstract description 246
• 102000014156 AMP-Activated Protein Kinases Human genes 0.000 abstract description 246
• 230000003993 interaction Effects 0.000 abstract description 26
• 239000000126 substance Substances 0.000 abstract description 14
• 108091000080 Phosphotransferase Proteins 0.000 abstract description 11
• 102000020233 phosphotransferase Human genes 0.000 abstract description 11
• 230000037149 energy metabolism Effects 0.000 abstract description 2
• 241000699670 Mus sp. Species 0.000 description 79
• 238000011282 treatment Methods 0.000 description 71
• 238000012360 testing method Methods 0.000 description 60
• 230000027455 binding Effects 0.000 description 54
• 239000012634 fragment Substances 0.000 description 51
• 210000004027 cell Anatomy 0.000 description 49
• 150000007523 nucleic acids Chemical class 0.000 description 41
• 230000001590 oxidative effect Effects 0.000 description 36
• 238000012549 training Methods 0.000 description 36
• 230000004913 activation Effects 0.000 description 35
• 102000039446 nucleic acids Human genes 0.000 description 32
• 108020004707 nucleic acids Proteins 0.000 description 32
• 229940079593 drug Drugs 0.000 description 30
• 235000001014 amino acid Nutrition 0.000 description 29
• 101000783681 Homo sapiens 5'-AMP-activated protein kinase catalytic subunit alpha-2 Proteins 0.000 description 27
• 239000000523 sample Substances 0.000 description 27
• 230000002103 transcriptional effect Effects 0.000 description 27
• 150000001413 amino acids Chemical class 0.000 description 26
• 102100036009 5'-AMP-activated protein kinase catalytic subunit alpha-2 Human genes 0.000 description 25
• 238000009472 formulation Methods 0.000 description 25
• 230000026731 phosphorylation Effects 0.000 description 23
• 238000006366 phosphorylation reaction Methods 0.000 description 23
• 241000699660 Mus musculus Species 0.000 description 21
• 210000001087 myotubule Anatomy 0.000 description 21
• 239000003981 vehicle Substances 0.000 description 21
• 102100040216 Mitochondrial uncoupling protein 3 Human genes 0.000 description 20
• 125000003275 alpha amino acid group Chemical group 0.000 description 20
• 238000011830 transgenic mouse model Methods 0.000 description 20
• 108010021098 Uncoupling Protein 3 Proteins 0.000 description 19
• 230000037444 atrophy Effects 0.000 description 19
• 230000001419 dependent effect Effects 0.000 description 19
• 239000000835 fiber Substances 0.000 description 17
• -1 mCPT I Proteins 0.000 description 17
• 102000005962 receptors Human genes 0.000 description 17
• 108020003175 receptors Proteins 0.000 description 17
• 206010003694 Atrophy Diseases 0.000 description 16
• 238000003556 assay Methods 0.000 description 16
• 210000001519 tissue Anatomy 0.000 description 16
• 238000013518 transcription Methods 0.000 description 16
• 230000035897 transcription Effects 0.000 description 16
• 230000033228 biological regulation Effects 0.000 description 15
• 230000004060 metabolic process Effects 0.000 description 15
• 239000000243 solution Substances 0.000 description 15
• 239000000090 biomarker Substances 0.000 description 14
• 230000006870 function Effects 0.000 description 14
• 239000003446 ligand Substances 0.000 description 14
• 102100034825 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial Human genes 0.000 description 13
• 230000008859 change Effects 0.000 description 13
• 230000004850 protein–protein interaction Effects 0.000 description 13
• 102000043296 Lipoprotein lipases Human genes 0.000 description 12
• 239000011324 bead Substances 0.000 description 12
• 230000004783 oxidative metabolism Effects 0.000 description 12
• 210000003314 quadriceps muscle Anatomy 0.000 description 12
• 230000009261 transgenic effect Effects 0.000 description 12
• 241001465754 Metazoa Species 0.000 description 11
• 210000003414 extremity Anatomy 0.000 description 11
• 230000002068 genetic effect Effects 0.000 description 11
• 230000002503 metabolic effect Effects 0.000 description 11
• 230000037081 physical activity Effects 0.000 description 11
• 108010083885 pyruvate dehydrogenase kinase 4 Proteins 0.000 description 11
• 230000009870 specific binding Effects 0.000 description 11
• 208000010428 Muscle Weakness Diseases 0.000 description 10
• 206010028372 Muscular weakness Diseases 0.000 description 10
• 230000002018 overexpression Effects 0.000 description 10
• 230000006611 pharmacological activation Effects 0.000 description 10
• 238000001262 western blot Methods 0.000 description 10
• 239000004480 active ingredient Substances 0.000 description 9
• 230000006978 adaptation Effects 0.000 description 9
• 238000004458 analytical method Methods 0.000 description 9
• 230000037396 body weight Effects 0.000 description 9
• 230000001413 cellular effect Effects 0.000 description 9
• 230000007423 decrease Effects 0.000 description 9
• 210000000663 muscle cell Anatomy 0.000 description 9
• 230000004044 response Effects 0.000 description 9
• 102000004190 Enzymes Human genes 0.000 description 8
• 108090000790 Enzymes Proteins 0.000 description 8
• 102000005604 Myosin Heavy Chains Human genes 0.000 description 8
• 108010084498 Myosin Heavy Chains Proteins 0.000 description 8
• 230000033115 angiogenesis Effects 0.000 description 8
• 238000001514 detection method Methods 0.000 description 8
• 201000010099 disease Diseases 0.000 description 8
• 239000002552 dosage form Substances 0.000 description 8
• 238000001543 one-way ANOVA Methods 0.000 description 8
• 102000040430 polynucleotide Human genes 0.000 description 8
• 108091033319 polynucleotide Proteins 0.000 description 8
• 239000002157 polynucleotide Substances 0.000 description 8
• 238000012216 screening Methods 0.000 description 8
• 230000019491 signal transduction Effects 0.000 description 8
• 230000011664 signaling Effects 0.000 description 8
• 210000001189 slow twitch fiber Anatomy 0.000 description 8
• 239000000758 substrate Substances 0.000 description 8
• 230000032258 transport Effects 0.000 description 8
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
• 241000282412 Homo Species 0.000 description 7
• 108091028043 Nucleic acid sequence Proteins 0.000 description 7
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
• 230000008901 benefit Effects 0.000 description 7
• 239000000969 carrier Substances 0.000 description 7
• 238000013270 controlled release Methods 0.000 description 7
• 230000000875 corresponding effect Effects 0.000 description 7
• 230000003247 decreasing effect Effects 0.000 description 7
• 235000013305 food Nutrition 0.000 description 7
• 108020004999 messenger RNA Proteins 0.000 description 7
• 229910052760 oxygen Inorganic materials 0.000 description 7
• 239000001301 oxygen Substances 0.000 description 7
• 239000000546 pharmaceutical excipient Substances 0.000 description 7
• MPLLLQUZNJSVTK-UHFFFAOYSA-N 5-[3-[4-[2-(4-fluorophenyl)ethoxy]phenyl]propyl]furan-2-carboxylic acid Chemical compound O1C(C(=O)O)=CC=C1CCCC(C=C1)=CC=C1OCCC1=CC=C(F)C=C1 MPLLLQUZNJSVTK-UHFFFAOYSA-N 0.000 description 6
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 6
• 241000287828 Gallus gallus Species 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• 229910019142 PO4 Inorganic materials 0.000 description 6
• 230000015572 biosynthetic process Effects 0.000 description 6
• 230000023852 carbohydrate metabolic process Effects 0.000 description 6
• 235000021256 carbohydrate metabolism Nutrition 0.000 description 6
• 238000006243 chemical reaction Methods 0.000 description 6
• 238000011161 development Methods 0.000 description 6
• 230000018109 developmental process Effects 0.000 description 6
• 238000000295 emission spectrum Methods 0.000 description 6
• 201000010063 epididymitis Diseases 0.000 description 6
• 239000008103 glucose Substances 0.000 description 6
• 230000036541 health Effects 0.000 description 6
• 230000001939 inductive effect Effects 0.000 description 6
• 208000014674 injury Diseases 0.000 description 6
• 230000001404 mediated effect Effects 0.000 description 6
• 230000002438 mitochondrial effect Effects 0.000 description 6
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
• 239000010452 phosphate Substances 0.000 description 6
• 230000010399 physical interaction Effects 0.000 description 6
• 230000036314 physical performance Effects 0.000 description 6
• 239000000843 powder Substances 0.000 description 6
• 230000002035 prolonged effect Effects 0.000 description 6
• 230000008672 reprogramming Effects 0.000 description 6
• 150000003431 steroids Chemical class 0.000 description 6
• 230000004936 stimulating effect Effects 0.000 description 6
• 238000013268 sustained release Methods 0.000 description 6
• 239000012730 sustained-release form Substances 0.000 description 6
• 102100030497 Cytochrome c Human genes 0.000 description 5
• 101150003888 FASN gene Proteins 0.000 description 5
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 5
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 5
• 108020005196 Mitochondrial DNA Proteins 0.000 description 5
• 102000005398 Monoacylglycerol Lipase Human genes 0.000 description 5
• 241000699666 Mus <mouse, genus> Species 0.000 description 5
• 102100030856 Myoglobin Human genes 0.000 description 5
• 108010062374 Myoglobin Proteins 0.000 description 5
• 101150078768 Pdk4 gene Proteins 0.000 description 5
• 238000011529 RT qPCR Methods 0.000 description 5
• 102000037054 SLC-Transporter Human genes 0.000 description 5
• 108091006207 SLC-Transporter Proteins 0.000 description 5
• 108700019146 Transgenes Proteins 0.000 description 5
• 208000027418 Wounds and injury Diseases 0.000 description 5
• 230000003321 amplification Effects 0.000 description 5
• 230000006907 apoptotic process Effects 0.000 description 5
• 230000008436 biogenesis Effects 0.000 description 5
• 230000001143 conditioned effect Effects 0.000 description 5
• 230000006378 damage Effects 0.000 description 5
• 239000000284 extract Substances 0.000 description 5
• 238000002866 fluorescence resonance energy transfer Methods 0.000 description 5
• 230000006698 induction Effects 0.000 description 5
• 210000002414 leg Anatomy 0.000 description 5
• 230000033001 locomotion Effects 0.000 description 5
• 230000003278 mimic effect Effects 0.000 description 5
• 238000003199 nucleic acid amplification method Methods 0.000 description 5
• 235000004252 protein component Nutrition 0.000 description 5
• 210000002966 serum Anatomy 0.000 description 5
• 230000035939 shock Effects 0.000 description 5
• 210000002807 slow-twitch muscle fiber Anatomy 0.000 description 5
• 238000010186 staining Methods 0.000 description 5
• 238000003860 storage Methods 0.000 description 5
• 230000002195 synergetic effect Effects 0.000 description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
• 101150099236 Acly gene Proteins 0.000 description 4
• 241000282472 Canis lupus familiaris Species 0.000 description 4
• 108010078791 Carrier Proteins Proteins 0.000 description 4
• 102000002585 Contractile Proteins Human genes 0.000 description 4
• 108010068426 Contractile Proteins Proteins 0.000 description 4
• 102000004127 Cytokines Human genes 0.000 description 4
• 108090000695 Cytokines Proteins 0.000 description 4
• 102100029721 DnaJ homolog subfamily B member 1 Human genes 0.000 description 4
• 108010042283 HSP40 Heat-Shock Proteins Proteins 0.000 description 4
• 101000978924 Homo sapiens Nuclear receptor subfamily 1 group D member 2 Proteins 0.000 description 4
• 102000043136 MAP kinase family Human genes 0.000 description 4
• 108091054455 MAP kinase family Proteins 0.000 description 4
• 102100023171 Nuclear receptor subfamily 1 group D member 2 Human genes 0.000 description 4
• 102100022676 Nuclear receptor subfamily 4 group A member 2 Human genes 0.000 description 4
• ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
• 229940049706 benzodiazepine Drugs 0.000 description 4
• 150000001557 benzodiazepines Chemical class 0.000 description 4
• 235000013361 beverage Nutrition 0.000 description 4
• 238000000749 co-immunoprecipitation Methods 0.000 description 4
• 206010012601 diabetes mellitus Diseases 0.000 description 4
• 230000004069 differentiation Effects 0.000 description 4
• 239000000499 gel Substances 0.000 description 4
• 238000002347 injection Methods 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• 238000011068 loading method Methods 0.000 description 4
• 239000003550 marker Substances 0.000 description 4
• 239000000463 material Substances 0.000 description 4
• 238000005259 measurement Methods 0.000 description 4
• 239000012528 membrane Substances 0.000 description 4
• 210000004379 membrane Anatomy 0.000 description 4
• 230000008437 mitochondrial biogenesis Effects 0.000 description 4
• 238000010369 molecular cloning Methods 0.000 description 4
• 230000037361 pathway Effects 0.000 description 4
• 230000004481 post-translational protein modification Effects 0.000 description 4
• 230000035755 proliferation Effects 0.000 description 4
• 238000012552 review Methods 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
• 101150055204 Acat2 gene Proteins 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 3
• 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 3
• 108010076365 Adiponectin Proteins 0.000 description 3
• 102000011690 Adiponectin Human genes 0.000 description 3
• 102100025674 Angiopoietin-related protein 4 Human genes 0.000 description 3
• 108010018763 Biotin carboxylase Proteins 0.000 description 3
• 101710186200 CCAAT/enhancer-binding protein Proteins 0.000 description 3
• 101150112561 CD36 gene Proteins 0.000 description 3
• 102000014914 Carrier Proteins Human genes 0.000 description 3
• 108091006146 Channels Proteins 0.000 description 3
• 101150065105 Cidec gene Proteins 0.000 description 3
• 102100024889 Cytochrome P450 2E1 Human genes 0.000 description 3
• 108010075031 Cytochromes c Proteins 0.000 description 3
• 101150102653 Dgat2 gene Proteins 0.000 description 3
• 101100323155 Dictyostelium discoideum snfA gene Proteins 0.000 description 3
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 3
• 101150097279 Dusp7 gene Proteins 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 101150082967 FABP3 gene Proteins 0.000 description 3
• 101150018889 FABP4 gene Proteins 0.000 description 3
• 108010054147 Hemoglobins Proteins 0.000 description 3
• 102000001554 Hemoglobins Human genes 0.000 description 3
• 101000693076 Homo sapiens Angiopoietin-related protein 4 Proteins 0.000 description 3
• 101000909131 Homo sapiens Cytochrome P450 2E1 Proteins 0.000 description 3
• 102100024580 L-lactate dehydrogenase B chain Human genes 0.000 description 3
• 101150114843 Mgll gene Proteins 0.000 description 3
• 102000007474 Multiprotein Complexes Human genes 0.000 description 3
• 108010085220 Multiprotein Complexes Proteins 0.000 description 3
• 101100220687 Mus musculus Cidea gene Proteins 0.000 description 3
• 101100340433 Mus musculus Ifi27l2a gene Proteins 0.000 description 3
• 208000008589 Obesity Diseases 0.000 description 3
• 229940126033 PPAR agonist Drugs 0.000 description 3
• 101150014691 PPARA gene Proteins 0.000 description 3
• 108010067902 Peptide Library Proteins 0.000 description 3
• 102000001253 Protein Kinase Human genes 0.000 description 3
• 241000700157 Rattus norvegicus Species 0.000 description 3
• QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 3
• 108010038912 Retinoid X Receptors Proteins 0.000 description 3
• 102000034527 Retinoid X Receptors Human genes 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 101150107180 Soat2 gene Proteins 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 101150071549 Thrsp gene Proteins 0.000 description 3
• LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 3
• 102000040945 Transcription factor Human genes 0.000 description 3
• 108091023040 Transcription factor Proteins 0.000 description 3
• 102000004338 Transferrin Human genes 0.000 description 3
• 108090000901 Transferrin Proteins 0.000 description 3
• 101150016260 UCP3 gene Proteins 0.000 description 3
• 239000012190 activator Substances 0.000 description 3
• 230000002411 adverse Effects 0.000 description 3
• 230000000386 athletic effect Effects 0.000 description 3
• 230000009286 beneficial effect Effects 0.000 description 3
• 239000011230 binding agent Substances 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 230000001351 cycling effect Effects 0.000 description 3
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
• 235000018417 cysteine Nutrition 0.000 description 3
• 230000002950 deficient Effects 0.000 description 3
• 208000037765 diseases and disorders Diseases 0.000 description 3
• 239000000975 dye Substances 0.000 description 3
• 230000037080 exercise endurance Effects 0.000 description 3
• 238000010195 expression analysis Methods 0.000 description 3
• 239000013604 expression vector Substances 0.000 description 3
• 239000000446 fuel Substances 0.000 description 3
• 230000002414 glycolytic effect Effects 0.000 description 3
• 210000000600 glycolytic muscle fiber Anatomy 0.000 description 3
• 239000008187 granular material Substances 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 238000009396 hybridization Methods 0.000 description 3
• 238000001114 immunoprecipitation Methods 0.000 description 3
• 239000007943 implant Substances 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 108010087599 lactate dehydrogenase 1 Proteins 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 3
• 230000007774 longterm Effects 0.000 description 3
• 210000003141 lower extremity Anatomy 0.000 description 3
• 239000012139 lysis buffer Substances 0.000 description 3
• 239000011159 matrix material Substances 0.000 description 3
• 208000030159 metabolic disease Diseases 0.000 description 3
• 230000003458 metachromatic effect Effects 0.000 description 3
• 238000010208 microarray analysis Methods 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 235000020824 obesity Nutrition 0.000 description 3
• 230000036284 oxygen consumption Effects 0.000 description 3
• 239000002307 peroxisome proliferator activated receptor agonist Substances 0.000 description 3
• 229940124531 pharmaceutical excipient Drugs 0.000 description 3
• 239000012071 phase Substances 0.000 description 3
• 108091005981 phosphorylated proteins Proteins 0.000 description 3
• 238000003752 polymerase chain reaction Methods 0.000 description 3
• 230000003389 potentiating effect Effects 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 108060006633 protein kinase Proteins 0.000 description 3
• 238000011002 quantification Methods 0.000 description 3
• 101150024910 rbp4 gene Proteins 0.000 description 3
• 230000002829 reductive effect Effects 0.000 description 3
• 238000007634 remodeling Methods 0.000 description 3
• 235000021283 resveratrol Nutrition 0.000 description 3
• 229940016667 resveratrol Drugs 0.000 description 3
• 230000035882 stress Effects 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 239000013589 supplement Substances 0.000 description 3
• 239000000829 suppository Substances 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 239000003826 tablet Substances 0.000 description 3
• 230000001225 therapeutic effect Effects 0.000 description 3
• 239000012581 transferrin Substances 0.000 description 3
• 238000012762 unpaired Student’s t-test Methods 0.000 description 3
• 230000003827 upregulation Effects 0.000 description 3
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• DVNYTAVYBRSTGK-UHFFFAOYSA-N 5-aminoimidazole-4-carboxamide Chemical compound NC(=O)C=1N=CNC=1N DVNYTAVYBRSTGK-UHFFFAOYSA-N 0.000 description 2
• HDZZVAMISRMYHH-UHFFFAOYSA-N 9beta-Ribofuranosyl-7-deazaadenin Natural products C1=CC=2C(N)=NC=NC=2N1C1OC(CO)C(O)C1O HDZZVAMISRMYHH-UHFFFAOYSA-N 0.000 description 2
• 101150090657 ADRB3 gene Proteins 0.000 description 2
• 108700038202 AMP-Activated Protein Kinase Kinases Proteins 0.000 description 2
• 101150054149 ANGPTL4 gene Proteins 0.000 description 2
• 101150085141 APLP2 gene Proteins 0.000 description 2
• 108091006112 ATPases Proteins 0.000 description 2
• 101150054866 Acadl gene Proteins 0.000 description 2
• 102000002735 Acyl-CoA Dehydrogenase Human genes 0.000 description 2
• 108010001058 Acyl-CoA Dehydrogenase Proteins 0.000 description 2
• 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 2
• 102000057290 Adenosine Triphosphatases Human genes 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• 102100040038 Amyloid beta precursor like protein 2 Human genes 0.000 description 2
• 101710168921 Amyloid beta precursor like protein 2 Proteins 0.000 description 2
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
• 108010013313 CLC-5 chloride channel Proteins 0.000 description 2
• 241000282465 Canis Species 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• 102000002666 Carnitine O-palmitoyltransferase Human genes 0.000 description 2
• 108010018424 Carnitine O-palmitoyltransferase Proteins 0.000 description 2
• 102100035882 Catalase Human genes 0.000 description 2
• 108010053835 Catalase Proteins 0.000 description 2
• 101150061453 Cebpa gene Proteins 0.000 description 2
• 101100235034 Danio rerio ldhba gene Proteins 0.000 description 2
• 101710088194 Dehydrogenase Proteins 0.000 description 2
• 238000002965 ELISA Methods 0.000 description 2
• 208000017701 Endocrine disease Diseases 0.000 description 2
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
• 101150063610 FBP2 gene Proteins 0.000 description 2
• 108010039731 Fatty Acid Synthases Proteins 0.000 description 2
• 102000030914 Fatty Acid-Binding Human genes 0.000 description 2
• 102100037738 Fatty acid-binding protein, heart Human genes 0.000 description 2
• 102100030892 Fructose-1,6-bisphosphatase isozyme 2 Human genes 0.000 description 2
• 102100034471 H(+)/Cl(-) exchange transporter 5 Human genes 0.000 description 2
• 101150021280 HIPK3 gene Proteins 0.000 description 2
• 102000004447 HSP40 Heat-Shock Proteins Human genes 0.000 description 2
• 102100021519 Hemoglobin subunit beta Human genes 0.000 description 2
• 101000726355 Homo sapiens Cytochrome c Proteins 0.000 description 2
• 101000866018 Homo sapiens DnaJ homolog subfamily B member 1 Proteins 0.000 description 2
• 101001027663 Homo sapiens Fatty acid-binding protein, heart Proteins 0.000 description 2
• 101001063910 Homo sapiens Fructose-1,6-bisphosphatase isozyme 2 Proteins 0.000 description 2
• 101000899111 Homo sapiens Hemoglobin subunit beta Proteins 0.000 description 2
• 101000685655 Homo sapiens Long-chain fatty acid transport protein 1 Proteins 0.000 description 2
• 101000747597 Homo sapiens Mitochondrial uncoupling protein 3 Proteins 0.000 description 2
• 101001109698 Homo sapiens Nuclear receptor subfamily 4 group A member 2 Proteins 0.000 description 2
• 101000803165 Homo sapiens Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform Proteins 0.000 description 2
• 101000620880 Homo sapiens Tartrate-resistant acid phosphatase type 5 Proteins 0.000 description 2
• 101000734339 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial Proteins 0.000 description 2
• 101150117895 LAMP2 gene Proteins 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 102000004882 Lipase Human genes 0.000 description 2
• 108090001060 Lipase Proteins 0.000 description 2
• 239000004367 Lipase Substances 0.000 description 2
• 102100023111 Long-chain fatty acid transport protein 1 Human genes 0.000 description 2
• 101150033762 MLYCD gene Proteins 0.000 description 2
• 108010081805 Malonyl-CoA decarboxylase Proteins 0.000 description 2
• 102100029461 Malonyl-CoA decarboxylase, mitochondrial Human genes 0.000 description 2
• 108010093175 Member 2 Group A Nuclear Receptor Subfamily 4 Proteins 0.000 description 2
• 102000006404 Mitochondrial Proteins Human genes 0.000 description 2
• 108010058682 Mitochondrial Proteins Proteins 0.000 description 2
• 102100038738 Mitochondrial carnitine/acylcarnitine carrier protein Human genes 0.000 description 2
• 101710118206 Mitochondrial carnitine/acylcarnitine carrier protein Proteins 0.000 description 2
• 102000004232 Mitogen-Activated Protein Kinase Kinases Human genes 0.000 description 2
• 108090000744 Mitogen-Activated Protein Kinase Kinases Proteins 0.000 description 2
• 101100503238 Mus musculus Folr2 gene Proteins 0.000 description 2
• 101100364277 Mus musculus Rsrp1 gene Proteins 0.000 description 2
• 208000008238 Muscle Spasticity Diseases 0.000 description 2
• 102000003505 Myosin Human genes 0.000 description 2
• 108060008487 Myosin Proteins 0.000 description 2
• 102100031455 NAD-dependent protein deacetylase sirtuin-1 Human genes 0.000 description 2
• 101150026563 NR4A2 gene Proteins 0.000 description 2
• 206010028980 Neoplasm Diseases 0.000 description 2
• 108010036505 Neutral Amino Acid Transport Systems Proteins 0.000 description 2
• 102000012106 Neutral Amino Acid Transport Systems Human genes 0.000 description 2
• 108091005461 Nucleic proteins Proteins 0.000 description 2
• 108091034117 Oligonucleotide Proteins 0.000 description 2
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
• 108700020796 Oncogene Proteins 0.000 description 2
• 208000002193 Pain Diseases 0.000 description 2
• 206010033799 Paralysis Diseases 0.000 description 2
• 229940122344 Peptidase inhibitor Drugs 0.000 description 2
• 108010001441 Phosphopeptides Proteins 0.000 description 2
• 229920000954 Polyglycolide Polymers 0.000 description 2
• 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 2
• 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 2
• 102000053067 Pyruvate Dehydrogenase Acetyl-Transferring Kinase Human genes 0.000 description 2
• 108700008625 Reporter Genes Proteins 0.000 description 2
• 101150071661 SLC25A20 gene Proteins 0.000 description 2
• 101150042597 Scd2 gene Proteins 0.000 description 2
• 102100035547 Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform Human genes 0.000 description 2
• 108010041191 Sirtuin 1 Proteins 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• 101150041750 Surf4 gene Proteins 0.000 description 2
• 102100022919 Tartrate-resistant acid phosphatase type 5 Human genes 0.000 description 2
• 102000004243 Tubulin Human genes 0.000 description 2
• 108090000704 Tubulin Proteins 0.000 description 2
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• 101710159466 [Pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial Proteins 0.000 description 2
• 229940100228 acetyl coenzyme a Drugs 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 230000003213 activating effect Effects 0.000 description 2
• 239000013543 active substance Substances 0.000 description 2
• 125000000539 amino acid group Chemical group 0.000 description 2
• 239000012491 analyte Substances 0.000 description 2
• 239000000427 antigen Substances 0.000 description 2
• 108091007433 antigens Proteins 0.000 description 2
• 102000036639 antigens Human genes 0.000 description 2
• 102000012740 beta Adrenergic Receptors Human genes 0.000 description 2
• 108010079452 beta Adrenergic Receptors Proteins 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• 108091008324 binding proteins Proteins 0.000 description 2
• 230000000975 bioactive effect Effects 0.000 description 2
• 238000001574 biopsy Methods 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 230000030833 cell death Effects 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• 230000006690 co-activation Effects 0.000 description 2
• 238000012761 co-transfection Methods 0.000 description 2
• 230000003750 conditioning effect Effects 0.000 description 2
• 230000006552 constitutive activation Effects 0.000 description 2
• 208000006111 contracture Diseases 0.000 description 2
• 230000036461 convulsion Effects 0.000 description 2
• 239000006071 cream Substances 0.000 description 2
• 230000003111 delayed effect Effects 0.000 description 2
• 238000003795 desorption Methods 0.000 description 2
• 150000001982 diacylglycerols Chemical class 0.000 description 2
• 238000010586 diagram Methods 0.000 description 2
• 238000006073 displacement reaction Methods 0.000 description 2
• 238000012377 drug delivery Methods 0.000 description 2
• 230000002526 effect on cardiovascular system Effects 0.000 description 2
• 239000012636 effector Substances 0.000 description 2
• 230000002124 endocrine Effects 0.000 description 2
• 230000019439 energy homeostasis Effects 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 108091022862 fatty acid binding Proteins 0.000 description 2
• 230000004129 fatty acid metabolism Effects 0.000 description 2
• 238000013467 fragmentation Methods 0.000 description 2
• 238000006062 fragmentation reaction Methods 0.000 description 2
• 238000013537 high throughput screening Methods 0.000 description 2
• 210000005260 human cell Anatomy 0.000 description 2
• 238000003018 immunoassay Methods 0.000 description 2
• 239000012133 immunoprecipitate Substances 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 238000007901 in situ hybridization Methods 0.000 description 2
• 238000000338 in vitro Methods 0.000 description 2
• 238000001727 in vivo Methods 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 230000002452 interceptive effect Effects 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 150000002500 ions Chemical class 0.000 description 2
• 238000000021 kinase assay Methods 0.000 description 2
• 238000002372 labelling Methods 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 101150100271 ldhb gene Proteins 0.000 description 2
• 235000019421 lipase Nutrition 0.000 description 2
• 230000037356 lipid metabolism Effects 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 230000004132 lipogenesis Effects 0.000 description 2
• 230000004130 lipolysis Effects 0.000 description 2
• 239000002502 liposome Substances 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 230000014759 maintenance of location Effects 0.000 description 2
• 238000004949 mass spectrometry Methods 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
• 229960003105 metformin Drugs 0.000 description 2
• 238000002493 microarray Methods 0.000 description 2
• 230000006540 mitochondrial respiration Effects 0.000 description 2
• 210000002161 motor neuron Anatomy 0.000 description 2
• 230000003387 muscular Effects 0.000 description 2
• 210000005036 nerve Anatomy 0.000 description 2
• 230000009871 nonspecific binding Effects 0.000 description 2
• 102000006255 nuclear receptors Human genes 0.000 description 2
• 108020004017 nuclear receptors Proteins 0.000 description 2
• 210000004287 null lymphocyte Anatomy 0.000 description 2
• 239000003921 oil Substances 0.000 description 2
• 235000019198 oils Nutrition 0.000 description 2
• 239000002674 ointment Substances 0.000 description 2
• 238000002966 oligonucleotide array Methods 0.000 description 2
• 239000002751 oligonucleotide probe Substances 0.000 description 2
• 208000035824 paresthesia Diseases 0.000 description 2
• 238000010647 peptide synthesis reaction Methods 0.000 description 2
• 210000000578 peripheral nerve Anatomy 0.000 description 2
• 239000008177 pharmaceutical agent Substances 0.000 description 2
• 230000000144 pharmacologic effect Effects 0.000 description 2
• 230000001766 physiological effect Effects 0.000 description 2
• 210000002381 plasma Anatomy 0.000 description 2
• 229920000747 poly(lactic acid) Polymers 0.000 description 2
• 239000004633 polyglycolic acid Substances 0.000 description 2
• 239000004626 polylactic acid Substances 0.000 description 2
• 239000011148 porous material Substances 0.000 description 2
• 239000003755 preservative agent Substances 0.000 description 2
• 208000026526 progressive weakness Diseases 0.000 description 2
• 238000000159 protein binding assay Methods 0.000 description 2
• 230000002285 radioactive effect Effects 0.000 description 2
• 238000003753 real-time PCR Methods 0.000 description 2
• 230000011514 reflex Effects 0.000 description 2
• 230000014493 regulation of gene expression Effects 0.000 description 2
• 210000003296 saliva Anatomy 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 238000010532 solid phase synthesis reaction Methods 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 238000000672 surface-enhanced laser desorption--ionisation Methods 0.000 description 2
• 239000006188 syrup Substances 0.000 description 2
• 235000020357 syrup Nutrition 0.000 description 2
• 230000009885 systemic effect Effects 0.000 description 2
• 210000002435 tendon Anatomy 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 210000002105 tongue Anatomy 0.000 description 2
• 230000000699 topical effect Effects 0.000 description 2
• 108091008023 transcriptional regulators Proteins 0.000 description 2
• 238000001890 transfection Methods 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 230000008733 trauma Effects 0.000 description 2
• 150000003626 triacylglycerols Chemical class 0.000 description 2
• HDZZVAMISRMYHH-KCGFPETGSA-N tubercidin Chemical compound C1=CC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O HDZZVAMISRMYHH-KCGFPETGSA-N 0.000 description 2
• 210000002700 urine Anatomy 0.000 description 2
• 239000013598 vector Substances 0.000 description 2
• 230000009184 walking Effects 0.000 description 2
• AOFUBOWZWQFQJU-SNOJBQEQSA-N (2r,3s,4s,5r)-2,5-bis(hydroxymethyl)oxolane-2,3,4-triol;(2s,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O AOFUBOWZWQFQJU-SNOJBQEQSA-N 0.000 description 1
• SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical class OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
• 102100026105 3-ketoacyl-CoA thiolase, mitochondrial Human genes 0.000 description 1
• 101150034014 48 gene Proteins 0.000 description 1
• 101150014538 ACP5 gene Proteins 0.000 description 1
• NOTGFIUVDGNKRI-UUOKFMHZSA-N AICA ribonucleotide Chemical compound NC1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 NOTGFIUVDGNKRI-UUOKFMHZSA-N 0.000 description 1
• 102100020969 ATP-binding cassette sub-family E member 1 Human genes 0.000 description 1
• 238000006064 ATPase reaction Methods 0.000 description 1
• 101150057674 Acaa2 gene Proteins 0.000 description 1
• 102000007476 Activating Transcription Factor 3 Human genes 0.000 description 1
• 108010085371 Activating Transcription Factor 3 Proteins 0.000 description 1
• 108020001558 Acyl-CoA oxidase Proteins 0.000 description 1
• 102100035785 Acyl-CoA-binding protein Human genes 0.000 description 1
• 108060003345 Adrenergic Receptor Proteins 0.000 description 1
• 102000017910 Adrenergic receptor Human genes 0.000 description 1
• 208000006888 Agnosia Diseases 0.000 description 1
• 241001047040 Agnosia Species 0.000 description 1
• 101710150365 Albumin-1 Proteins 0.000 description 1
• 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
• 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 1
• 102100040743 Alpha-crystallin B chain Human genes 0.000 description 1
• 206010002091 Anaesthesia Diseases 0.000 description 1
• 102100039181 Ankyrin repeat domain-containing protein 1 Human genes 0.000 description 1
• 102000008102 Ankyrins Human genes 0.000 description 1
• 108010049777 Ankyrins Proteins 0.000 description 1
• 102100034613 Annexin A2 Human genes 0.000 description 1
• 108090000668 Annexin A2 Proteins 0.000 description 1
• 206010003062 Apraxia Diseases 0.000 description 1
• 208000006820 Arthralgia Diseases 0.000 description 1
• 206010003497 Asphyxia Diseases 0.000 description 1
• 206010003591 Ataxia Diseases 0.000 description 1
• 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
• 101150068685 BTG2 gene Proteins 0.000 description 1
• 108010077805 Bacterial Proteins Proteins 0.000 description 1
• 102100036597 Basement membrane-specific heparan sulfate proteoglycan core protein Human genes 0.000 description 1
• 102100030516 Beta-crystallin B1 Human genes 0.000 description 1
• 102000004506 Blood Proteins Human genes 0.000 description 1
• 108010017384 Blood Proteins Proteins 0.000 description 1
• 208000010392 Bone Fractures Diseases 0.000 description 1
• 206010006482 Bronchospasm Diseases 0.000 description 1
• 101150098688 CLCN5 gene Proteins 0.000 description 1
• 101150063057 CRYAB gene Proteins 0.000 description 1
• 206010006895 Cachexia Diseases 0.000 description 1
• 102000004631 Calcineurin Human genes 0.000 description 1
• 108010042955 Calcineurin Proteins 0.000 description 1
• 208000004652 Cardiovascular Abnormalities Diseases 0.000 description 1
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 102100027943 Carnitine O-palmitoyltransferase 1, liver isoform Human genes 0.000 description 1
• 101710120614 Carnitine O-palmitoyltransferase 1, liver isoform Proteins 0.000 description 1
• 102100027947 Carnitine O-palmitoyltransferase 1, muscle isoform Human genes 0.000 description 1
• 101710108984 Carnitine O-palmitoyltransferase 1, muscle isoform Proteins 0.000 description 1
• 206010007710 Cartilage injury Diseases 0.000 description 1
• 241000272165 Charadriidae Species 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 102000004057 Claudin-5 Human genes 0.000 description 1
• 108090000582 Claudin-5 Proteins 0.000 description 1
• 241001503987 Clematis vitalba Species 0.000 description 1
• 108010060434 Co-Repressor Proteins Proteins 0.000 description 1
• 102000008169 Co-Repressor Proteins Human genes 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 102100025680 Complement decay-accelerating factor Human genes 0.000 description 1
• 208000032170 Congenital Abnormalities Diseases 0.000 description 1
• 241000777300 Congiopodidae Species 0.000 description 1
• 101150104864 Crygf gene Proteins 0.000 description 1
• 208000014311 Cushing syndrome Diseases 0.000 description 1
• 229920000858 Cyclodextrin Polymers 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• 102100033688 DNA ligase 3 Human genes 0.000 description 1
• 230000004568 DNA-binding Effects 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 101100202237 Danio rerio rxrab gene Proteins 0.000 description 1
• 101100309320 Danio rerio rxrga gene Proteins 0.000 description 1
• 101100161150 Danio rerio ywhag1 gene Proteins 0.000 description 1
• 206010061619 Deformity Diseases 0.000 description 1
• 208000019505 Deglutition disease Diseases 0.000 description 1
• 102100037458 Dephospho-CoA kinase Human genes 0.000 description 1
• 108010039287 Diazepam Binding Inhibitor Proteins 0.000 description 1
• 101100457042 Dictyostelium discoideum mgst gene Proteins 0.000 description 1
• 108010016626 Dipeptides Proteins 0.000 description 1
• 206010013642 Drooling Diseases 0.000 description 1
• 101100011517 Drosophila melanogaster ELOVL gene Proteins 0.000 description 1
• 206010013887 Dysarthria Diseases 0.000 description 1
• 102100029501 E3 ubiquitin-protein ligase TRIM35 Human genes 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 102000003951 Erythropoietin Human genes 0.000 description 1
• 108090000394 Erythropoietin Proteins 0.000 description 1
• 208000004657 Exercise-Induced Asthma Diseases 0.000 description 1
• 102100027186 Extracellular superoxide dismutase [Cu-Zn] Human genes 0.000 description 1
• 108700001268 Extracellular superoxide dismutase [Cu-Zn] Proteins 0.000 description 1
• 108091006010 FLAG-tagged proteins Proteins 0.000 description 1
• 208000001308 Fasciculation Diseases 0.000 description 1
• 108010062715 Fatty Acid Binding Protein 3 Proteins 0.000 description 1
• 102000011026 Fatty Acid Binding Protein 3 Human genes 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 208000036119 Frailty Diseases 0.000 description 1
• 101150083125 GGCX gene Proteins 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 102100024008 Glycerol-3-phosphate acyltransferase 1, mitochondrial Human genes 0.000 description 1
• 101150058655 Gpam gene Proteins 0.000 description 1
• 102000007369 HSP110 Heat-Shock Proteins Human genes 0.000 description 1
• 108010032952 HSP110 Heat-Shock Proteins Proteins 0.000 description 1
• 101150101832 HSPA9 gene Proteins 0.000 description 1
• 101150006108 HSPB7 gene Proteins 0.000 description 1
• 101710113864 Heat shock protein 90 Proteins 0.000 description 1
• 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 description 1
• 102000003964 Histone deacetylase Human genes 0.000 description 1
• 108090000353 Histone deacetylase Proteins 0.000 description 1
• 101000835276 Homo sapiens 3-ketoacyl-CoA thiolase, mitochondrial Proteins 0.000 description 1
• 101000783786 Homo sapiens ATP-binding cassette sub-family E member 1 Proteins 0.000 description 1
• 101000891982 Homo sapiens Alpha-crystallin B chain Proteins 0.000 description 1
• 101000889396 Homo sapiens Ankyrin repeat domain-containing protein 1 Proteins 0.000 description 1
• 101000919505 Homo sapiens Beta-crystallin B1 Proteins 0.000 description 1
• 101000856022 Homo sapiens Complement decay-accelerating factor Proteins 0.000 description 1
• 101000927847 Homo sapiens DNA ligase 3 Proteins 0.000 description 1
• 101000952691 Homo sapiens Dephospho-CoA kinase Proteins 0.000 description 1
• 101000634987 Homo sapiens E3 ubiquitin-protein ligase TRIM35 Proteins 0.000 description 1
• 101000904268 Homo sapiens Glycerol-3-phosphate acyltransferase 1, mitochondrial Proteins 0.000 description 1
• 101001016865 Homo sapiens Heat shock protein HSP 90-alpha Proteins 0.000 description 1
• 101000872458 Homo sapiens Huntingtin-interacting protein 1-related protein Proteins 0.000 description 1
• 101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 description 1
• 101000958753 Homo sapiens Myosin-2 Proteins 0.000 description 1
• 101001024286 Homo sapiens Notchless protein homolog 1 Proteins 0.000 description 1
• 101000741790 Homo sapiens Peroxisome proliferator-activated receptor gamma Proteins 0.000 description 1
• 101000933604 Homo sapiens Protein BTG2 Proteins 0.000 description 1
• 101000686225 Homo sapiens Ras-related GTP-binding protein D Proteins 0.000 description 1
• 101001077409 Homo sapiens Ras-related protein Rab-5B Proteins 0.000 description 1
• 101000806266 Homo sapiens Very-long-chain 3-oxoacyl-CoA reductase Proteins 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• 102100034773 Huntingtin-interacting protein 1-related protein Human genes 0.000 description 1
• 208000037171 Hypercorticoidism Diseases 0.000 description 1
• 208000035154 Hyperesthesia Diseases 0.000 description 1
• 208000008017 Hypohidrosis Diseases 0.000 description 1
• 206010021118 Hypotonia Diseases 0.000 description 1
• 101150002416 Igf2 gene Proteins 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
• 102100025947 Insulin-like growth factor II Human genes 0.000 description 1
• 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 description 1
• 101710152369 Interleukin-6 receptor subunit beta Proteins 0.000 description 1
• 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
• 101150026829 JUNB gene Proteins 0.000 description 1
• 206010023230 Joint stiffness Diseases 0.000 description 1
• 102100040290 LIM homeobox transcription factor 1-alpha Human genes 0.000 description 1
• 101710178355 LIM homeobox transcription factor 1-alpha Proteins 0.000 description 1
• 108010092277 Leptin Proteins 0.000 description 1
• 102000016267 Leptin Human genes 0.000 description 1
• 101150100520 MPV17 gene Proteins 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 101710094503 Metallothionein-1 Proteins 0.000 description 1
• 102100031347 Metallothionein-2 Human genes 0.000 description 1
• 101710094505 Metallothionein-2 Proteins 0.000 description 1
• 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 1
• 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 208000006670 Multiple fractures Diseases 0.000 description 1
• 101100123481 Mus musculus Hbb-b2 gene Proteins 0.000 description 1
• 101100092284 Mus musculus Rragd gene Proteins 0.000 description 1
• 101100160981 Mus musculus Zmym3 gene Proteins 0.000 description 1
• 208000007379 Muscle Hypotonia Diseases 0.000 description 1
• 208000002740 Muscle Rigidity Diseases 0.000 description 1
• 208000029578 Muscle disease Diseases 0.000 description 1
• 206010049565 Muscle fatigue Diseases 0.000 description 1
• 101150027506 Mybph gene Proteins 0.000 description 1
• 102100038303 Myosin-2 Human genes 0.000 description 1
• 102100030626 Myosin-binding protein H Human genes 0.000 description 1
• 101710139548 Myosin-binding protein H Proteins 0.000 description 1
• GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 102100035358 Notchless protein homolog 1 Human genes 0.000 description 1
• 108091093105 Nuclear DNA Proteins 0.000 description 1
• 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
• 108010049358 Oncogene Protein p65(gag-jun) Proteins 0.000 description 1
• 240000007594 Oryza sativa Species 0.000 description 1
• 235000007164 Oryza sativa Nutrition 0.000 description 1
• 208000033952 Paralysis flaccid Diseases 0.000 description 1
• 208000018737 Parkinson disease Diseases 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 108091093037 Peptide nucleic acid Proteins 0.000 description 1
• 102100038831 Peroxisome proliferator-activated receptor alpha Human genes 0.000 description 1
• 102100038824 Peroxisome proliferator-activated receptor delta Human genes 0.000 description 1
• 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 1
• 229920001710 Polyorthoester Polymers 0.000 description 1
• 102100026034 Protein BTG2 Human genes 0.000 description 1
• 101150001354 Ptpn2 gene Proteins 0.000 description 1
• 101150050070 RXRA gene Proteins 0.000 description 1
• 241000270934 Rana catesbeiana Species 0.000 description 1
• 102100025002 Ras-related GTP-binding protein D Human genes 0.000 description 1
• 102100025132 Ras-related protein Rab-5B Human genes 0.000 description 1
• 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
• 206010070833 Respiratory muscle weakness Diseases 0.000 description 1
• 102100022986 Retbindin Human genes 0.000 description 1
• 101710182968 Retbindin Proteins 0.000 description 1
• 102000007508 Retinoblastoma-Binding Protein 4 Human genes 0.000 description 1
• 108010071034 Retinoblastoma-Binding Protein 4 Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 101150052317 SAP30 gene Proteins 0.000 description 1
• 101710157343 Seminal vesicle secretory protein 4 Proteins 0.000 description 1
• 206010040030 Sensory loss Diseases 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 102000007562 Serum Albumin Human genes 0.000 description 1
• 108010071390 Serum Albumin Proteins 0.000 description 1
• 208000008630 Sialorrhea Diseases 0.000 description 1
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
• 102000011990 Sirtuin Human genes 0.000 description 1
• 108050002485 Sirtuin Proteins 0.000 description 1
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
• 102000013275 Somatomedins Human genes 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 101710172711 Structural protein Proteins 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 101150006974 Svs4 gene Proteins 0.000 description 1
• 101150093886 TGFBR2 gene Proteins 0.000 description 1
• 101150044705 TRIM35 gene Proteins 0.000 description 1
• WFWLQNSHRPWKFK-UHFFFAOYSA-N Tegafur Chemical compound O=C1NC(=O)C(F)=CN1C1OCCC1 WFWLQNSHRPWKFK-UHFFFAOYSA-N 0.000 description 1
• 244000269722 Thea sinensis Species 0.000 description 1
• 102000002932 Thiolase Human genes 0.000 description 1
• 108060008225 Thiolase Proteins 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 102100023132 Transcription factor Jun Human genes 0.000 description 1
• 102000009618 Transforming Growth Factors Human genes 0.000 description 1
• 108010009583 Transforming Growth Factors Proteins 0.000 description 1
• 102000004271 Tryptophan 5-monooxygenases Human genes 0.000 description 1
• 108090000885 Tryptophan 5-monooxygenases Proteins 0.000 description 1
• 101150025935 Tspo gene Proteins 0.000 description 1
• 238000010162 Tukey test Methods 0.000 description 1
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
• 102100037438 Very-long-chain 3-oxoacyl-CoA reductase Human genes 0.000 description 1
• 101150083738 YWHAG gene Proteins 0.000 description 1
• 102100025417 Zinc finger MYM-type protein 3 Human genes 0.000 description 1
• 101710162002 Zinc finger MYM-type protein 3 Proteins 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 239000008186 active pharmaceutical agent Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 230000003044 adaptive effect Effects 0.000 description 1
• 150000003838 adenosines Chemical class 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 201000005255 adrenal gland hyperfunction Diseases 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 238000000246 agarose gel electrophoresis Methods 0.000 description 1
• 238000011292 agonist therapy Methods 0.000 description 1
• 230000003281 allosteric effect Effects 0.000 description 1
• VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
• 238000005267 amalgamation Methods 0.000 description 1
• 230000037354 amino acid metabolism Effects 0.000 description 1
• 230000037005 anaesthesia Effects 0.000 description 1
• 230000002491 angiogenic effect Effects 0.000 description 1
• 206010002512 anhidrosis Diseases 0.000 description 1
• 230000037001 anhydrosis Effects 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000001028 anti-proliverative effect Effects 0.000 description 1
• 201000007201 aphasia Diseases 0.000 description 1
• 206010003549 asthenia Diseases 0.000 description 1
• 238000000376 autoradiography Methods 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 238000002869 basic local alignment search tool Methods 0.000 description 1
• RNBGYGVWRKECFJ-ARQDHWQXSA-N beta-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ARQDHWQXSA-N 0.000 description 1
• 230000002146 bilateral effect Effects 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 229920002988 biodegradable polymer Polymers 0.000 description 1
• 239000004621 biodegradable polymer Substances 0.000 description 1
• 229920001400 block copolymer Polymers 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 229940124630 bronchodilator Drugs 0.000 description 1
• 239000000168 bronchodilator agent Substances 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 239000007894 caplet Substances 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 230000000747 cardiac effect Effects 0.000 description 1
• 230000002612 cardiopulmonary effect Effects 0.000 description 1
• 230000002802 cardiorespiratory effect Effects 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000005754 cellular signaling Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 239000013626 chemical specie Substances 0.000 description 1
• 235000012000 cholesterol Nutrition 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 230000009194 climbing Effects 0.000 description 1
• 238000011260 co-administration Methods 0.000 description 1
• 230000003081 coactivator Effects 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 239000005515 coenzyme Substances 0.000 description 1
• 239000005516 coenzyme A Substances 0.000 description 1
• 229940093530 coenzyme a Drugs 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 238000004040 coloring Methods 0.000 description 1
• 238000002648 combination therapy Methods 0.000 description 1
• 230000002301 combined effect Effects 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 238000004883 computer application Methods 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 235000008504 concentrate Nutrition 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 229940097362 cyclodextrins Drugs 0.000 description 1
• WBNUBZZHHXFAGK-UHFFFAOYSA-N cycloheptylthiourea Chemical compound NC(=S)NC1CCCCCC1 WBNUBZZHHXFAGK-UHFFFAOYSA-N 0.000 description 1
• 239000000850 decongestant Substances 0.000 description 1
• 229940124581 decongestants Drugs 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000006735 deficit Effects 0.000 description 1
• 230000002638 denervation Effects 0.000 description 1
• 230000008021 deposition Effects 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 235000013367 dietary fats Nutrition 0.000 description 1
• 235000015872 dietary supplement Nutrition 0.000 description 1
• 210000002249 digestive system Anatomy 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 230000003292 diminished effect Effects 0.000 description 1
• 239000007884 disintegrant Substances 0.000 description 1
• 239000002934 diuretic Substances 0.000 description 1
• 229940030606 diuretics Drugs 0.000 description 1
• 231100000673 dose–response relationship Toxicity 0.000 description 1
• 230000003828 downregulation Effects 0.000 description 1
• 239000013583 drug formulation Substances 0.000 description 1
• 229940126534 drug product Drugs 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 208000026500 emaciation Diseases 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 230000007368 endocrine function Effects 0.000 description 1
• 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 230000002270 ergogenic effect Effects 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 230000000925 erythroid effect Effects 0.000 description 1
• 229940105423 erythropoietin Drugs 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 238000013265 extended release Methods 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 210000001512 fast-twitch muscle fiber Anatomy 0.000 description 1
• 230000004136 fatty acid synthesis Effects 0.000 description 1
• 150000002190 fatty acyls Chemical group 0.000 description 1
• 230000002550 fecal effect Effects 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 208000028331 flaccid paralysis Diseases 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• 235000013312 flour Nutrition 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 230000037406 food intake Effects 0.000 description 1
• 235000012631 food intake Nutrition 0.000 description 1
• 235000003599 food sweetener Nutrition 0.000 description 1
• 239000012458 free base Substances 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 235000020510 functional beverage Nutrition 0.000 description 1
• 235000013376 functional food Nutrition 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000003633 gene expression assay Methods 0.000 description 1
• 230000030279 gene silencing Effects 0.000 description 1
• 230000004190 glucose uptake Effects 0.000 description 1
• YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
• SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
• 101150052418 gw gene Proteins 0.000 description 1
• 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
• 230000002440 hepatic effect Effects 0.000 description 1
• 150000001469 hydantoins Chemical class 0.000 description 1
• 239000000017 hydrogel Substances 0.000 description 1
• JUMYIBMBTDDLNG-OJERSXHUSA-N hydron;methyl (2r)-2-phenyl-2-[(2r)-piperidin-2-yl]acetate;chloride Chemical compound Cl.C([C@@H]1[C@H](C(=O)OC)C=2C=CC=CC=2)CCCN1 JUMYIBMBTDDLNG-OJERSXHUSA-N 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• 208000003532 hypothyroidism Diseases 0.000 description 1
• 230000002989 hypothyroidism Effects 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 230000002055 immunohistochemical effect Effects 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 230000002621 immunoprecipitating effect Effects 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 230000030214 innervation Effects 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 230000003914 insulin secretion Effects 0.000 description 1
• 229940068935 insulin-like growth factor 2 Drugs 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 210000004347 intestinal mucosa Anatomy 0.000 description 1
• 238000007917 intracranial administration Methods 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000007914 intraventricular administration Methods 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 230000003447 ipsilateral effect Effects 0.000 description 1
• 230000002427 irreversible effect Effects 0.000 description 1
• 208000028867 ischemia Diseases 0.000 description 1
• 235000015110 jellies Nutrition 0.000 description 1
• 239000008274 jelly Substances 0.000 description 1
• 208000017169 kidney disease Diseases 0.000 description 1
• 210000003127 knee Anatomy 0.000 description 1
• 210000000867 larynx Anatomy 0.000 description 1
• 239000008141 laxative Substances 0.000 description 1
• 229940125722 laxative agent Drugs 0.000 description 1
• 150000002611 lead compounds Chemical class 0.000 description 1
• NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
• 229940039781 leptin Drugs 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 108020001756 ligand binding domains Proteins 0.000 description 1
• 238000007834 ligase chain reaction Methods 0.000 description 1
• 208000027905 limb weakness Diseases 0.000 description 1
• 231100000861 limb weakness Toxicity 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 230000004322 lipid homeostasis Effects 0.000 description 1
• 230000013190 lipid storage Effects 0.000 description 1
• 239000008297 liquid dosage form Substances 0.000 description 1
• 239000012263 liquid product Substances 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
• ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
• 239000001095 magnesium carbonate Substances 0.000 description 1
• 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
• 229910052753 mercury Inorganic materials 0.000 description 1
• 238000001466 metabolic labeling Methods 0.000 description 1
• 230000037353 metabolic pathway Effects 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 235000010981 methylcellulose Nutrition 0.000 description 1
• 229960001033 methylphenidate hydrochloride Drugs 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 239000003595 mist Substances 0.000 description 1
• 230000001483 mobilizing effect Effects 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
• 210000002200 mouth mucosa Anatomy 0.000 description 1
• 239000002324 mouth wash Substances 0.000 description 1
• 229940051866 mouthwash Drugs 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 230000004118 muscle contraction Effects 0.000 description 1
• 210000003098 myoblast Anatomy 0.000 description 1
• 229930014626 natural product Natural products 0.000 description 1
• 238000002663 nebulization Methods 0.000 description 1
• 239000006199 nebulizer Substances 0.000 description 1
• 210000003739 neck Anatomy 0.000 description 1
• 208000015122 neurodegenerative disease Diseases 0.000 description 1
• 230000002232 neuromuscular Effects 0.000 description 1
• 208000018360 neuromuscular disease Diseases 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 239000000820 nonprescription drug Substances 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 230000012223 nuclear import Effects 0.000 description 1
• 235000016709 nutrition Nutrition 0.000 description 1
• 230000035764 nutrition Effects 0.000 description 1
• 238000003305 oral gavage Methods 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 201000008482 osteoarthritis Diseases 0.000 description 1
• 201000008968 osteosarcoma Diseases 0.000 description 1
• 239000006179 pH buffering agent Substances 0.000 description 1
• 230000036407 pain Effects 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 230000004963 pathophysiological condition Effects 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 239000000816 peptidomimetic Substances 0.000 description 1
• 238000011056 performance test Methods 0.000 description 1
• 230000010412 perfusion Effects 0.000 description 1
• 210000005259 peripheral blood Anatomy 0.000 description 1
• 239000011886 peripheral blood Substances 0.000 description 1
• 208000033808 peripheral neuropathy Diseases 0.000 description 1
• 108010049224 perlecan Proteins 0.000 description 1
• 108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 description 1
• 108091008765 peroxisome proliferator-activated receptors β/δ Proteins 0.000 description 1
• 239000003208 petroleum Substances 0.000 description 1
• 238000002823 phage display Methods 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 239000002831 pharmacologic agent Substances 0.000 description 1
• 238000011458 pharmacological treatment Methods 0.000 description 1
• 210000003800 pharynx Anatomy 0.000 description 1
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
• 230000000865 phosphorylative effect Effects 0.000 description 1
• 230000010254 physiological adaptation Effects 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
• 229920001610 polycaprolactone Polymers 0.000 description 1
• 229920002721 polycyanoacrylate Polymers 0.000 description 1
• 229920006324 polyoxymethylene Polymers 0.000 description 1
• 210000004896 polypeptide structure Anatomy 0.000 description 1
• 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 1
• 230000001124 posttranscriptional effect Effects 0.000 description 1
• 230000001323 posttranslational effect Effects 0.000 description 1
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 239000000047 product Substances 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
• 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 230000004952 protein activity Effects 0.000 description 1
• 238000002331 protein detection Methods 0.000 description 1
• 230000004853 protein function Effects 0.000 description 1
• 239000003531 protein hydrolysate Substances 0.000 description 1
• 230000009822 protein phosphorylation Effects 0.000 description 1
• 230000020978 protein processing Effects 0.000 description 1
• 238000010379 pull-down assay Methods 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 150000003235 pyrrolidines Chemical class 0.000 description 1
• 238000003127 radioimmunoassay Methods 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 108091006091 regulatory enzymes Proteins 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 201000004193 respiratory failure Diseases 0.000 description 1
• 208000023504 respiratory system disease Diseases 0.000 description 1
• 230000024977 response to activity Effects 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000003757 reverse transcription PCR Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 235000009566 rice Nutrition 0.000 description 1
• 238000005096 rolling process Methods 0.000 description 1
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
• 102000009023 sarcolipin Human genes 0.000 description 1
• 108010088766 sarcolipin Proteins 0.000 description 1
• 231100000241 scar Toxicity 0.000 description 1
• 210000001625 seminal vesicle Anatomy 0.000 description 1
• 239000008299 semisolid dosage form Substances 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 108091009872 serum response element binding proteins Proteins 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 230000007781 signaling event Effects 0.000 description 1
• 239000000741 silica gel Substances 0.000 description 1
• 229910002027 silica gel Inorganic materials 0.000 description 1
• 235000020183 skimmed milk Nutrition 0.000 description 1
• 239000010454 slate Substances 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
• 239000007909 solid dosage form Substances 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 238000002764 solid phase assay Methods 0.000 description 1
• 239000012265 solid product Substances 0.000 description 1
• 239000006104 solid solution Substances 0.000 description 1
• 238000001179 sorption measurement Methods 0.000 description 1
• 239000003549 soybean oil Substances 0.000 description 1
• 235000012424 soybean oil Nutrition 0.000 description 1
• 230000001148 spastic effect Effects 0.000 description 1
• 208000018198 spasticity Diseases 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 230000003595 spectral effect Effects 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 208000020431 spinal cord injury Diseases 0.000 description 1
• 210000000273 spinal nerve root Anatomy 0.000 description 1
• 230000037078 sports performance Effects 0.000 description 1
• 230000009192 sprinting Effects 0.000 description 1
• 239000000021 stimulant Substances 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 210000004243 sweat Anatomy 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 230000009182 swimming Effects 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 150000003505 terpenes Chemical class 0.000 description 1
• 206010056873 tertiary syphilis Diseases 0.000 description 1
• 238000011287 therapeutic dose Methods 0.000 description 1
• 229940098465 tincture Drugs 0.000 description 1
• 230000009772 tissue formation Effects 0.000 description 1
• 238000013271 transdermal drug delivery Methods 0.000 description 1
• 229940100640 transdermal system Drugs 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 230000014616 translation Effects 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
• 230000009452 underexpressoin Effects 0.000 description 1
• 238000010200 validation analysis Methods 0.000 description 1
• 230000003966 vascular damage Effects 0.000 description 1
• 235000013311 vegetables Nutrition 0.000 description 1
• 201000010653 vesiculitis Diseases 0.000 description 1
• 230000002747 voluntary effect Effects 0.000 description 1
• 238000004260 weight control Methods 0.000 description 1
• 230000004584 weight gain Effects 0.000 description 1
• 235000019786 weight gain Nutrition 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 238000003158 yeast two-hybrid assay Methods 0.000 description 1